Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris
NCT05761158 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 21
Last updated 2025-04-24
Summary
The prevalence of pruritus has been studied in frontal fibrosis alopecia (FFA) and lichen planus pilaris (LPP), but there are no studies evaluating the characteristics of pruritus, the correlation between pruritus and disease activity, and its impact on quality of life.
The knowledge of the characteristics of pruritus, of the link "disease activity - pruritus", and its impact on the quality of life could allow us to modify the management of the patient (modification or intensification of therapy, close monitoring...)
Conditions
- Alopecia
- Lichen Planus
Interventions
- OTHER
-
questionnaire
patients are asked to complete a questionnaire
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-14
- Primary Completion
- 2023-05-25
- Completion
- 2023-05-25
Countries
- France
Study Locations
More Related Trials
-
Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
NCT06801821 ·Status: RECRUITING
-
Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus
NCT00285779 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis
NCT04128007 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Spa Therapy in the Treatment of Plaque Psoriasis
NCT02098213 ·Status: COMPLETED ·Phase: NA
-
Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and Psoriasis
NCT06448689 ·Status: RECRUITING
-
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
NCT05144165 ·Status: UNKNOWN
-
Systematic Review And Meta-Analysis Of Psoriasis Treatments.
NCT01425138 ·Status: COMPLETED
-
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
NCT03540160 ·Status: TERMINATED ·Phase: PHASE3
-
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
NCT03546816 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients
NCT04765332 ·Status: COMPLETED
-
Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
NCT05642182 ·Status: RECRUITING ·Phase: PHASE1
-
To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris
NCT00050648 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
NCT01230138 ·Status: COMPLETED ·Phase: PHASE2
-
Benralizumab in Chronic Prurigo - Investigating Clinical Efficacy (BICPIC)
NCT05528913 ·Status: WITHDRAWN ·Phase: PHASE2
-
Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis
NCT03553433 ·Status: UNKNOWN ·Phase: PHASE4
-
Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis
NCT00184366 ·Status: TERMINATED
-
Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of Prevalence
NCT04566471 ·Status: UNKNOWN
-
Regulatory T Cells (Tregs) in Polymorphic Light Eruption
NCT00555178 ·Status: COMPLETED
-
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment
NCT03791216 ·Status: COMPLETED
-
Valchlor in the Treatment of Lichen Planopilaris
NCT03417141 ·Status: COMPLETED ·Phase: PHASE2
-
Lichen Planus Mucosae at USZ, Efficacy of Oral Alitretinoin
NCT01538732 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study Examining the Medication Apremilast as Treatment for Chronic Itch
NCT03239106 ·Status: COMPLETED ·Phase: PHASE2
-
Work Stress and Impact of Pruritus on Quality of Life
NCT04316533 ·Status: COMPLETED
-
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
NCT03895372 ·Status: COMPLETED ·Phase: PHASE2
-
Involvement of Pollutants in Atopic Dermatitis and Psoriasis
NCT06213688 ·Status: NOT_YET_RECRUITING ·Phase: NA